claim
Fukumoto et al. (2019) demonstrated that activity-dependent brain-derived neurotrophic factor (BDNF) signaling is required for the antidepressant effects of (2R,6R)-hydroxynorketamine.

Authors

Sources

Referenced by nodes (2)